|

Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.

RECRUITINGN/ASponsored by Instituto de Investigación Sanitaria Aragón
Actively Recruiting
PhaseN/A
SponsorInstituto de Investigación Sanitaria Aragón
Started2025-05-01
Est. completion2026-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This Randomized Controlled Trial (RCT) aims to assess the effectiveness and acceptability of the Unified Protocol (UP) in an online group format for the treatment of emotional disorders in adults. Participants will be 90 adults (45 in the control group and 45 in the experimental group) with diagnosis of long COVID and comorbid emotional disorders. Participants will be recruited at Hospital Royo Villanova from Zaragoza, Spain. In this study it will be explored whether the changes obtained after the intervention in emotional disorders and cognitive complaints are maintained over 12 months. Additionally, levels of chronic stress will be longitudinally evaluated in the experimental group through accumulated cortisol levels in hair, before and after the application of the UP.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Residing in Autonomous Community of Aragon (Spain).
* Being at least 18 years old.
* Understanding of Spanish.
* Being diagnosed with long COVID-19: documented SARS-CoV-2 infection and persistence of symptoms beyond 12 weeks after the acute infection.
* Symptoms of depression (ODSIS≥7) and/or anxiety (OASIS≥8).
* Meeting the criteria for an emotional disorder diagnosis.
* Having access to Internet.
* Signing the informed consent.

Exclusion Criteria:

* Pre-existing emotional symptoms prior to the acute SARS-CoV-2 infection.
* Actually receiving psychological treatment.
* Having a diagnosis of severe mental disorder (e.g., personality disorder, bipolar disorder, etc.).
* Active suicidal ideation at the time of the assessment.
* Individuals on psychotropic medication must maintain their dosage throughout the study, unless medically contraindicated.

Conditions6

AnxietyDepressionDepression DisordersEmotion RegulationEmotional DisorderLong COVID-19

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.